Core Scientific Inc (CORZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,935,480 | 1,065,392 | 311,378 | 453,443 | 581,345 |
| Other current assets | 508,164 | 389,440 | 584,159 | 607,590 | 423,415 |
| TOTAL | $2,443,644 | $1,454,832 | $895,537 | $1,061,033 | $1,004,760 |
| Non-Current Assets | |||||
| PPE Net | 1,774,142 | 1,344,924 | 1,293,299 | 1,078,803 | 828,603 |
| Intangibles | 228,625 | 0 | 1,076 | 0 | 0 |
| Other Non-Current Assets | 811,082 | 269,808 | 157,732 | 156,144 | 144,689 |
| TOTAL | $2,813,849 | $1,614,732 | $1,452,107 | $1,234,947 | $973,292 |
| Total Assets | $5,257,493 | $3,069,564 | $2,347,644 | $2,295,980 | $1,978,052 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 112,374 | 218,857 | 126,106 | 212,179 | 215,055 |
| Accrued Expenses | 509,189 | 364,479 | 511,957 | 358,270 | 180,641 |
| Other current liabilities | 1,829,030 | 864,948 | 15,777 | 15,675 | 16,899 |
| TOTAL | $2,737,794 | $2,661,783 | $781,401 | $669,863 | $562,722 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,297,967 | N/A | 1,060,325 | N/A | N/A |
| Deferred Revenues | 287,201 | 219,555 | 127,561 | 83,739 | 150,127 |
| Other Non-Current Liabilities | 273,846 | 1,278,795 | 1,040,368 | 2,754,077 | 2,480,006 |
| TOTAL | $4,939,055 | $1,713,467 | $2,528,983 | $2,754,077 | $2,480,006 |
| Total Liabilities | $7,676,849 | $4,375,250 | $3,310,384 | $3,423,940 | $3,042,728 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 321,340 | 317,885 | 315,333 | 310,061 | 305,408 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -5,649,201 | -4,493,891 | -4,146,703 | -4,237,984 | -4,091,324 |
| TOTAL | $-2,419,356 | $-1,305,686 | $-962,740 | $-1,127,960 | $-1,064,676 |
| Total Liabilities And Equity | $5,257,493 | $3,069,564 | $2,347,644 | $2,295,980 | $1,978,052 |